Factors Affecting Best-Tolerated Dose of Pirfenidone in Patients with Fibrosing Interstitial Lung Disease

The aim of the study was to examine the best-tolerated dose of pirfenidone, the adverse effects profile, and potential factors other than drug dose influencing the tolerability of pirfenidone in patients with fibrosing interstitial lung diseases (ILDs). We performed an observational retrospective st...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandovra, Neha P., Vaidya, Preyas J., Shah, Ria S., Nighojkar, Aishwarya S., Chavhan, Vinod B., Lohiya, Ayush, Leuppi, Joerg D., Leuppi-Taegtmeyer, Anne, Chhajed, Prashant N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606989/
https://www.ncbi.nlm.nih.gov/pubmed/37892651
http://dx.doi.org/10.3390/jcm12206513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606989/
https://www.ncbi.nlm.nih.gov/pubmed/37892651
http://dx.doi.org/10.3390/jcm12206513

Ejemplares similares